| Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia | |
| Xu Binghe; Kim Sung-Bae; Inoue Kenichi; Lee JuRueyJiuan; Zhang Bo; Bryce Richard; Chow Louis W-C | |
| 2019 | |
| 关键词 | Asia HER2 efficacy metastatic breast cancer neratinib pooled analysis safety tyrosine kinase inhibitor |
| ISSN号 | 1744-8301 |
| DOI | 10.2217/fon-2019-0222 |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6338264 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Xu Binghe,Kim Sung-Bae,Inoue Kenichi,et al. Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia[J],2019. |
| APA | Xu Binghe.,Kim Sung-Bae.,Inoue Kenichi.,Lee JuRueyJiuan.,Zhang Bo.,...&Chow Louis W-C.(2019).Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia.. |
| MLA | Xu Binghe,et al."Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia".(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论